Cargando…
Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
Lung squamous cell carcinoma (LUSC) is a leading cause of mobidity and mortality worldwide. Recently, there was a shift in the treatment pattern of immune therapy in LUSC patients; merely a small number of patients with non-small cell lung cancer (NSCLC) at advanced stages respond well to immune che...
Autores principales: | Xie, Xiaona, Tang, Yemeng, Sheng, Jueqi, Shu, Pingping, Zhu, Xiayan, Cai, Xueding, Zhao, Chengguang, Wang, Liangxing, Huang, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566981/ https://www.ncbi.nlm.nih.gov/pubmed/34746153 http://dx.doi.org/10.3389/fcell.2021.761758 |
Ejemplares similares
-
Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021) -
Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021) -
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
por: Mo, Shu-Fen, et al.
Publicado: (2023) -
Roles of Embryonic Lethal Abnormal Vision-Like RNA Binding Proteins in Cancer and Beyond
por: Cai, Haijian, et al.
Publicado: (2022) -
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)